BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6435359)

  • 1. [Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial].
    Nikitiuk NM; Sumarokov AA; Nefedova LA; Pavlova LI; Kostiukova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):72-6. PubMed ID: 6435359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
    Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of a meningococcal-B erythrocyte diagnostic agent based on the group-specific polysaccharide].
    Martynov IuV; Demina AA; Alliluev AP; Kotel'nikova OV; Kuvakina VI; Marinin IIu; Korneeva SA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):63-9. PubMed ID: 2129075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
    Hassan-King M; Greenwood BM; Whittle HC
    J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of different meningococcal group-specific erythrocyte diagnostic kits in passive hemagglutination test].
    Tumanian AA; Mishina AI; Smirnova-Matusheva MA; Golovina LI; Nikitiuk NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):91-4. PubMed ID: 6412493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross-reacting intraspecies antigens of Neisseria meningitidis. II. The dynamics of antimeningococcal antibodies to cross-reacting antigens in different forms of meningococcal infection].
    Martynov IuV; Gracheva AM; Samsonova IM; Mol'kova LSh; Petina GK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):60-5. PubMed ID: 6084377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of meningococcal antibodies by a radial hemolysis method].
    Martynov IuV; Samsonova IM; Demina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):27-30. PubMed ID: 6441396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the reactogenic and immunogenic properties of meningococcal vaccines].
    Demina AA; Parunina TM; Deviatkin NP; Martynov IuV; Koroleva IS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):88-92. PubMed ID: 6441402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antibody response of animals to a corpuscular meningococcal group-B preparation with different methods of immunization].
    Aleksakhina NN; Basnak'ian IA; Kolenko VM; Borovkova VM; Saraeva LV; Stukalova NV; Karabak VI
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):30-4. PubMed ID: 1466168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for familial immune defect in meningococcal meningitis.
    Whittle HC; Oduloju A; Evans-Jones G; Greenwood BM
    Br Med J; 1976 May; 1(6020):1247-50. PubMed ID: 817771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety, reactogenicity and immunological activity of a group A meningococcal polysaccharide vaccine for children 1-4 years old].
    Chernyshova TF; Mishina AI; Pavlova LI; Pokrovskaia NIa; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 May; (5):54-8. PubMed ID: 3113138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal inoculation doses of meningococcal chemical polyvalent ABC vaccine for immunizing children of various ages and adolescents. I. Safety and reactogenicity of different dosages of the preparation].
    Ganzenko VP; Sumarokov AA; Nikonova VA; Filipov IuV; Valcarcel Novo M
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):44-54. PubMed ID: 6818797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
    Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
    J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.
    Ceesay SJ; Allen SJ; Menon A; Todd JE; Cham K; Carlone GM; Turner SH; Gheesling LL; DeWitt W; Plikaytis BD
    J Infect Dis; 1993 May; 167(5):1212-6. PubMed ID: 8486957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Broud DD; Altieri PL; Berman SL
    Mil Med; 1985 Oct; 150(10):529-33. PubMed ID: 3934585
    [No Abstract]   [Full Text] [Related]  

  • 18. [New approach to the diagnosis of meningococcal infection: latex-erythrocyte agglutination].
    Martynov IuV; Samsonova IM; Blinkovskiĭ AM
    Biull Eksp Biol Med; 1990 Apr; 109(4):369-71. PubMed ID: 2117473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal inoculation doses of meningococcal chemical polyvalent ABC-vaccine for immunizing children of different ages. II. A study of the immunological effectiveness of different doses of the preparation].
    Ganzenko VP; Sumarokov AA; Nikonova VA; Filippov IuV; Valcarcel Novo M
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):23-6. PubMed ID: 6408855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.
    Wahdan MH; Sallam SA; Hassan MN; Abdel Gawad A; Rakha AS; Sippel JE; Hablas R; Sanborn WR; Kassem NM; Riad SM; Cvjetanović B
    Bull World Health Organ; 1977; 55(6):645-51. PubMed ID: 413639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.